Revenue Breakdown
Composition ()
No data
Revenue Streams
Cigna Group (CI) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Pharmacy revenues, accounting for 80.4% of total sales, equivalent to $56.05B. Other significant revenue streams include Premiums and Fees and other revenues. Understanding this composition is critical for investors evaluating how CI navigates market cycles within the Managed Healthcare industry.
Profitability & Margins
Evaluating the bottom line, Cigna Group maintains a gross margin of 8.22%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 3.53%, while the net margin is 1.76%. These profitability ratios, combined with a Return on Equity (ROE) of 14.40%, provide a clear picture of how effectively CI converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, CI competes directly with industry leaders such as ELV and HUM. With a market capitalization of $74.82B, it holds a leading position in the sector. When comparing efficiency, CI's gross margin of 8.22% stands against ELV's N/A and HUM's N/A. Such benchmarking helps identify whether Cigna Group is trading at a premium or discount relative to its financial performance.
